Clinical trial approval / initiation

Explore the landscape of Clinical trial approval / initiation in China’s pharmaceutical industry. Fineline Info & Tech delivers reliable data and insights on Clinical trial approval / initiation to help you navigate complexities with precision and clarity. Stay informed and enhance your decision-making at flcube.com.

Zhongsheng Pharma's RAY1225 Achieves 22.2% Weight Loss in Phase III REBUILDING‑2 Trial – Biweekly GLP‑1/GIP Dual Agonist Outperforms Tirzepatide Response Rates on Key Thresholds
CompanyDrug

Zhongsheng Pharma’s RAY1225 Achieves 22.2% Weight Loss in Phase III REBUILDING‑2 Trial – Biweekly GLP‑1/GIP Dual Agonist Outperforms Tirzepatide Response Rates on Key Thresholds

Guangdong Zhongsheng Pharmaceutical Co., Ltd. (SHE: 002317) announced positive topline results from its Phase III REBUILDING‑2 clinical trial evaluating RAY1225 Injection (Bilpatide Injection), a first‑in‑class dual GLP‑1/GIP receptor agonist with…

Lifotronic Technology's H100Plus HbA1c Testing System Receives FDA 510(k) Clearance – Chinese IVD Company Gains U.S. Market Access for Diabetes Diagnostics

Lifotronic Technology’s H100Plus HbA1c Testing System Receives FDA 510(k) Clearance – Chinese IVD Company Gains U.S. Market Access for Diabetes Diagnostics

Hinova Pharmaceuticals' HP515 Phase IIa MASH Data Accepted as AASLD 2026 Late‑Breaking Abstract – THR‑β Agonist Achieves >50% Liver Fat Reduction With No SAEs

Hinova Pharmaceuticals’ HP515 Phase IIa MASH Data Accepted as AASLD 2026 Late‑Breaking Abstract – THR‑β Agonist Achieves >50% Liver Fat Reduction With No SAEs

Empowering Chinese Pharma’s Global Expansion

Leverage premier media reach to connect your pipeline with global partners. Contact us to drive your international growth today.
Explore Now
CompanyDrug

Bayer’s 225Ac-PSMA-Trillium Therapy Begins Early-Stage Clinical Trial for mCRPC

CompanyDrug

Roc Rock Biotechnology Secures Ethical Approval for CAR-M Therapy in Ovarian Cancer

CompanyDrug

Olymvax Biopharmaceuticals Gets Green Light for Tetravalent Influenza Vaccine Clinical Trial

CompanyDrug

Insilico Medicine’s ISM8207 Enters Phase I Clinical Trial for Lymphoma and Solid Tumors

CompanyDrug

Fosun Pharmaceutical Advances Lasofocine Clinical Trials for Breast Cancer after NMPA Nod

CompanyDrug

Jiangsu Hengrui’s SHR-2173 Gets Green Light for Clinical Trial in IgA Nephropathy

CompanyDrug

Tonghua Dongbao Pharmaceuticals Begins Clinical Trial for Xultophy Biosimilar

CompanyDrug

RemeGen’s Telitacicept Achieves Full Enrollment in Phase III Primary Sjogren’s Syndrome Trial

Show More